| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,235 | 1,604 | 2,766 | 3,523 | | Cost of Revenue | 4,020 | 1,078 | 1,464 | 1,036 | | | Gross Profit | 3,215 | 526 | 1,302 | 2,487 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,277) | 2,078 | 2,281 | 1,991 | | Non Recurring | 34,594 | 6,431 | 16,819 | 21,521 | | Others | 2,319 | 916 | 1,828 | 2,645 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (32,421) | (8,899) | (19,626) | (23,670) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (917) | (530) | 2,141 | 2,546 | | Earnings Before Interest And Taxes | (38,886) | (9,429) | (17,485) | (21,124) | | Interest Expense | 76 | 30 | 25 | 29 | | Income Before Tax | (38,962) | (9,459) | (17,510) | (21,153) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (38,962) | (9,459) | (17,510) | (21,153) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (38,962) | (9,459) | (17,510) | (21,153) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($38,962) | ($9,459) | ($17,510) | ($21,153) |
|
0.11% Nasdaq 
0.01%
Income Statement
